159 related articles for article (PubMed ID: 30318784)
21. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation.
Carroll PA; Brazeau E; Lagunoff M
Virology; 2004 Oct; 328(1):7-18. PubMed ID: 15380353
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.
Aoki Y; Jaffe ES; Chang Y; Jones K; Teruya-Feldstein J; Moore PS; Tosato G
Blood; 1999 Jun; 93(12):4034-43. PubMed ID: 10361100
[TBL] [Abstract][Full Text] [Related]
24. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.
Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C
Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315
[TBL] [Abstract][Full Text] [Related]
26. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
27. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages.
Bhaskaran N; Ghosh SK; Yu X; Qin S; Weinberg A; Pandiyan P; Ye F
Cell Cycle; 2017; 16(17):1611-1621. PubMed ID: 28750175
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
30. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation.
Wu J; Xu Y; Mo D; Huang P; Sun R; Huang L; Pan S; Xu J
PLoS One; 2014; 9(3):e93478. PubMed ID: 24675762
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic and vascular origin of Kaposi's sarcoma spindle cells during tumor development.
Pyakurel P; Pak F; Mwakigonja AR; Kaaya E; Heiden T; Biberfeld P
Int J Cancer; 2006 Sep; 119(6):1262-7. PubMed ID: 16615115
[TBL] [Abstract][Full Text] [Related]
33. Looking for the target cell of Kaposi's sarcoma-associated herpesvirus.
Dupin N; Grange PA
J Invest Dermatol; 2006 Mar; 126(3):545-7. PubMed ID: 16482196
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.
Choi HS; Jain V; Krueger B; Marshall V; Kim CH; Shisler JL; Whitby D; Renne R
PLoS Pathog; 2015; 11(11):e1005255. PubMed ID: 26545119
[TBL] [Abstract][Full Text] [Related]
35. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
36. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma.
Pellet C; Kerob D; Dupuy A; Carmagnat MV; Mourah S; Podgorniak MP; Toledano C; Morel P; Vérola O; Dosquet C; Hamel Y; Calvo F; Rabian C; Lebbé C
J Invest Dermatol; 2006 Mar; 126(3):621-7. PubMed ID: 16410791
[TBL] [Abstract][Full Text] [Related]
38. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
39. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
